Anti-VEGFR2 / KDR / CD309 Reference Antibody (ramucirumab)

SKU: orb1818268

Description

Recombinant Antibody

Images & Validation

• Tested Applications: ELISA, FC
• Reactivity: Human, Monkey

Key Properties

• Antibody Type: Primary Antibody
• Clonality: Monoclonal
• Isotype: IgG1
• Source/Expression System: CHO Cell
• Protein Sequence: VEGFR2 / KDR / CD309
• Molecular Weight: 143.8
• Endotoxin: < 0.001EU/μg,determined by LAL method.
• Conjugation: Unconjugated

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
• Form/Appearance: Purified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column.
• Concentration: 1mg/ml
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Vascular endothelial growth factor receptor 2, VEGFR-2, 2.7.10.1, Fetal liver kinase 1, FLK-1, Kinase insert domain receptor, KDR, Protein-tyrosine kinase receptor flk-1, CD309, KDR (HGNC:6307), FLK1, VEGFR2

The purity of Anti-VEGFR2 / KDR / CD309 Reference Antibody (ramucirumab) is more than 99.36%, determined by SEC-HPLC.

Immobilized human VGFR2 His at4 µg/mL can bind Anti-VEGFR2 / KDR / CD309 Reference Antibody (ramucirumab), EC50=0.007088 µg/mL

Anti-VEGFR2 / KDR / CD309 Reference Antibody (ramucirumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%

VEGFR2/NFAT-Luci-HEK293 cells were stained with Anti-VEGFR2 / KDR / CD309 Reference Antibody (ramucirumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC279=0.8009 nM

Quick Database Links

UniProt

P35968